Clinical trial
MK-0524B Lipid Study (MK-0524B-063)
NCT00479882 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00479882 |
|---|---|
| Title | MK-0524B Lipid Study (MK-0524B-063) |
| Official title | A Multicenter, Randomized, Double-Blind, "Crossover" Design Study to Evaluate the Lipid-Altering Efficacy and Safety of MK-0524B Combination Tablet Compared to MK-0524A + Simvastatin Coadministration in Patients With Primary Hypercholesterolemia and Mixed Dyslipidemia |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Primary Hypercholesterolemia, Mixed Dyslipidemia |
| Intervention type | Drug |
| Interventions | Comparator: simvastatin, MK-0524A, Placebo, MK-0524B |
| Enrollment | 2,414 |
| Start date | Jun 15, 2007 |
| Primary completion | Jun 16, 2008 |
| Completion | Jun 16, 2008 |
| First posted | May 28, 2007 |
| Last update posted | Feb 6, 2019 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: